Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Quantitative PCR detection of t(11;14) bcl-1/JH in mantle cell lymphoma patients: comparison of peripheral blood and bone marrow aspirate samples.

Di Martino S, Catapano O, Siesto SR, Di Paolo M, Pugliese S, Morelli CD, Fiorica F, Varriale E, Di Francia R, Abbadessa A.

Eur Rev Med Pharmacol Sci. 2015 Dec;19(24):4801-10.

3.
4.

Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow.

Gribben JG, Neuberg D, Barber M, Moore J, Pesek KW, Freedman AS, Nadler LM.

Blood. 1994 Jun 15;83(12):3800-7.

PMID:
8204898
5.
6.

Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma.

Gribben JG, Neuberg D, Freedman AS, Gimmi CD, Pesek KW, Barber M, Saporito L, Woo SD, Coral F, Spector N, et al.

Blood. 1993 Jun 15;81(12):3449-57.

PMID:
8507880
7.

Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma.

Welzel N, Le T, Marculescu R, Mitterbauer G, Chott A, Pott C, Kneba M, Du MQ, Kusec R, Drach J, Raderer M, Mannhalter C, Lechner K, Nadel B, Jaeger U.

Cancer Res. 2001 Feb 15;61(4):1629-36.

8.

Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.

Vose JM.

Am J Hematol. 2013 Dec;88(12):1082-8. doi: 10.1002/ajh.23615. Review.

9.

Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.

Vose JM.

Am J Hematol. 2012 Jun;87(6):604-9. doi: 10.1002/ajh.23176. Review.

10.

Cyclin D1 mRNA as a molecular marker for minimal residual disease monitoring in patients with mantle cell lymphoma.

Lokvenc M, Kalinova M, Forsterova K, Klener P, Trneny M, Fronkova E, Kodet R.

Ann Hematol. 2018 Mar;97(3):467-474. doi: 10.1007/s00277-017-3210-8. Epub 2017 Dec 22.

PMID:
29273915
11.

Common consensus LNA probe for quantitative PCR assays in cancer: vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas.

Sørensen CD, Jørgensen JM, Nederby L, Hokland P, Nyvold CG.

J Immunol Methods. 2014 Apr;406:131-6. doi: 10.1016/j.jim.2014.03.004. Epub 2014 Mar 13.

PMID:
24631717
12.

Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease.

Andersen NS, Donovan JW, Borus JS, Poor CM, Neuberg D, Aster JC, Nadler LM, Freedman AS, Gribben JG.

Blood. 1997 Nov 15;90(10):4212-21.

PMID:
9354694
13.

Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.

Vose JM.

Am J Hematol. 2015 Aug;90(8):739-45. doi: 10.1002/ajh.24094. Review.

14.

Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.

Mangel J, Buckstein R, Imrie K, Spaner D, Crump M, Tompkins K, Reis M, Perez-Ordonez B, Deodhare S, Romans R, Pennell N, Robinson JB, Hewitt K, Richardson P, Lima A, Pavlin P, Berinstein NL.

Semin Oncol. 2002 Feb;29(1 Suppl 2):56-69. Review.

PMID:
11842390
15.

Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.

Papajík T, Jedlicková K, Kriegová E, Jarosová M, Raida L, Faber E, Hubácek J, Vondráková J, Pikalová Z, Indrák K.

Neoplasma. 2001;48(6):501-5.

PMID:
11949845
16.

A novel bcl-1/JH breakpoint from a patient affected by mantle cell lymphoma extends the major translocation cluster.

Degan M, Doliana R, Gloghini A, Di Francia R, Aldinucci D, Mazzocut-Zecchin L, Colombatti A, Attadia V, Carbone A, Gattei V.

J Pathol. 2002 Jun;197(2):256-63.

PMID:
12015751
18.

Clinical and prognostic significance of monoclonal small cells in the peripheral blood and bone marrow of various B-cell lymphomas.

Nakano M, Kawanishi Y, Kuge S, Kuriyama Y, Kuwabara S, Yaguchi M, Toyama K.

Blood. 1992 Jun 15;79(12):3253-60.

PMID:
1375848
19.

Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.

Pott C, Schrader C, Brüggemann M, Ritgen M, Harder L, Raff T, Tiemann M, Dreger P, Kneba M.

Eur J Haematol. 2005 Apr;74(4):353-8.

PMID:
15777349
20.

Real-time RT-PCR assay for quantifying cyclin D1 mRNA in B-cell non-Hodgkin's lymphomas.

Medeiros LJ, Hai S, Thomazy VA, Estalilla OC, Romaguera J, Luthra R.

Mod Pathol. 2002 May;15(5):556-64.

Supplemental Content

Support Center